U.S. public health officials received a surprising directive to halt all collaborations with the World Health Organization (WHO) following a memo from CDC official John Nkengasong. This abrupt policy halts technical working group engagements, advisory roles, and onsite visits, raising concerns about the implications for fighting diseases like Marburg virus and mpox in Africa. The directive aligns with President Trump’s recent executive order to withdraw from the WHO, although formal withdrawal requires Congressional approval and financial compliance. Experts predict this sudden shift will significantly disrupt ongoing global health initiatives.
The sudden stoppage of U.S. cooperation with WHO will significantly hinder efforts to combat emerging health threats like Marburg virus and mpox.
Experts are alarmed by the abrupt nature of the cessation in collaboration, highlighting that it has blindsided public health professionals.
Dr. Jeffrey Klausner noted the interruption in communication with WHO could severely hinder critical global health initiatives and partnerships.
This decision reflects a noteworthy pivot in U.S. public health strategy, as concerns about upcoming threats grow amid a tightening grip on WHO relationships.
Collection
[
|
...
]